Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Aminobisphosphonates versus other active treatment for Paget's disease of the bone in adults

Esta versión no es la más reciente

ver la versión actual 01 diciembre 2017

Información

DOI:
https://doi.org/10.1002/14651858.CD004956Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2004see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Salud musculoesquelética

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Anne L Langston

    Correspondencia a: Health Services Research Unit, University of Aberdeen, Aberdeen, UK

    [email protected]

  • Marion K Campbell

    Health Services Research Unit, University of Aberdeen, Aberdeen, UK

  • Stuart Ralston

    Institute of Medical Sciences, University of Aberdeen Medical School, Aberdeen, UK

  • Clare Robertson

    Health Services Research Unit, University of Aberdeen, Aberdeen, UK

Contributions of authors

AL Langston ‐ Preparation of protocol
MK Campbell ‐ Methodological input; proof‐reading
SH Ralston ‐ Clinical input; proof‐reading
C Robertson ‐ Proof‐reading

Declarations of interest

SHR acts as a consultant for Proctor & Gamble, Aventis Pharma, and Novartis, which are pharmaceutical companies that manufacture drugs used in the treatment of Paget's disease of bone (PDB). All of the authors have also received funding from the Arthritis Research Campaign, National Association for the Relief of Paget's Disease, and The Alliance for Better Bone Health (Proctor & Gamble, and Aventis Pharma) for the PRISM trial of treatment strategies in PDB. All authors are involved in the management of the PRISM trial: SHR is the principal investigator; MKC is a grant holder; ALL is the trial manager; CR is the trial research assistant.

Version history

Published

Title

Stage

Authors

Version

2017 Dec 01

Bisphosphonates for Paget's disease of bone in adults

Review

Luis Corral‐Gudino, Adrian JH Tan, Javier del Pino‐Montes, Stuart H Ralston

https://doi.org/10.1002/14651858.CD004956.pub3

2014 Oct 10

Bisphosphonates for Paget's disease of bone in adults

Protocol

Luis Corral‐Gudino, Adrian JH Tan, Stuart Ralston

https://doi.org/10.1002/14651858.CD004956.pub2

2004 Oct 18

Aminobisphosphonates versus other active treatment for Paget's disease of the bone in adults

Protocol

Anne L Langston, Marion K Campbell, Stuart Ralston, Clare Robertson

https://doi.org/10.1002/14651858.CD004956

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Aged; Female; Humans; Male;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.